— Know what they know.
Not Investment Advice

ALT NASDAQ

Altimmune, Inc.
1W: -10.5% 1M: -16.5% 3M: -11.0% YTD: -41.6% 1Y: -20.4% 3Y: +6.2% 5Y: -76.3%
$2.73
-0.03 (-0.91%)
 
Weekly Expected Move ±6.4%
$2 $3 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 32 · $531.9M mcap · 184M float · 2.28% daily turnover · Short 53% of daily vol

Supply Chain Overview

5 relationships
5
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2025-11-06
Earliest Filing
2026-01-28
Latest Filing
partner: 5

Counterparties (Filed by ALT)

5 relationships

Companies named in ALT's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Titan Partners Group LLC KMCM partner Placement agent for the registered direct offering 2026-01-28 View
American Capital Partners, LLC AIG partner Parent company of Titan Partners Group LLC 2026-01-28 View
Leerink Partners LLC — partner Sales agent for the November 2025 at-the-market offering program 2025-11-06 View
Piper Sandler & Co. PIPR partner Sales agent for the terminated February 2025 at-the-market offering program 2025-11-06 View
Stifel, Nicolaus & Company, Incorporated — partner Sales agent for the terminated February 2025 at-the-market offering program 2025-11-06 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-29 Officer/Director Change View
2026-08-12 Earnings Release; Exhibits View
2026-07-28 Regulation FD; Other Events; Exhibits View
2026-06-16 Other Events View
2026-05-13 Earnings Release; Exhibits View
2026-04-24 Material Agreement; Exhibits Agreement View
2026-04-16 Bylaws Amendment; Shareholder Vote; Exhibits View
2026-03-05 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-02-03 Other Events View
2026-01-28 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-12-19 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-12-01 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2025-11-06 Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Creation of Agreement View
2025-11-06 Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Financial St Agreement View
2025-10-03 Departure/Election of Directors; Appointment of Officers View
2025-09-25 Submission of Matters to a Vote of Security Holders View
2025-08-12 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-06-26 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-05-13 Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Creation of Agreement View
2025-03-13 Other Events View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms